Trial Profile
A Proof-of-Concept, Randomized, Double-Blind and Placebo Controlled Clinical Trial With Naltrexone and Clonidine Combination (ATNC05) Compared With Placebo in the Treatment of Chronic Back Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2023
Price :
$35
*
At a glance
- Drugs ALLOD 2 (Primary)
- Indications Back pain; Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- 12 Sep 2012 Planned End Date changed from 1 Aug 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov record.
- 15 Aug 2011 New trial record